Harvard Ave Acquisition Corporation Unit

NASDAQ:HAVAU

Shell Companies

Financial Services
$10.32 -0.00%

-$0.00 today

Market cap
$153.15M
Beta
0.03
P/E (TTM)
194.6
EPS (TTM)
$0.05
52W Low $9.98High $11.03

Volume 0.00M

Average 0.00M

HAVAU Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Harvard Ave Acquisition Corporation UnitNASDAQ: HAVAU

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents remains negative

Q1 FY2026 cash & equivalents was $0, compared with $5.68K a year earlier.

Context

  • Cash & equivalents amounted to 0.0% of total assets at the end of Q1 FY2026, down 2.0 pp from a year earlier.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0-100.0% YoY
Year agoMar 2025
$5.68K-100.0% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Cash & Equivalents vs competitors

How HAVAU compares with its peers on the latest reported figures

  • HAVAU's Mar 2026 cash & equivalents of $0 is the lowest of the 7 companies compared; the peer median is $661.63K.
  • Its year-over-year change of -100.0% is the lowest of 6, against a peer median of +24.5%.
  • Cash & equivalents amounts to 0.0% of total assets for HAVAU, versus a peer median of 0.8%.
HAVAU Competitors Peer median
Cash & Equivalents for HAVAU and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CPBICentral Plains Bancshares, Inc. Common StockDec 2025$7.73M +24.5%—1.4%
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary SharesMar 2026$2.8M +11108.6%—1.2%
BSAABEST SPAC I Acquisition Corp.Mar 2026$1.17M ——2.0%
EURKEureka Acquisition Corp Class A Ordinary ShareMar 2026$151.62K -57.3%—0.5%
AFJKAimei Health Technology Co., LtdMar 2026$18.52K +152.1%—0.2%
RIBBRibbon Acquisition CorpMar 2026$1.88K -99.6%—0.0%
HAVAUHarvard Ave Acquisition Corporation UnitMar 2026$0 -100.0%—0.0%
Peer median (excluding HAVAU) $661.63K+24.5%—0.8%

Competitors are the stored peer set for HAVAU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Harvard Ave Acquisition Corporation Unit

NASDAQ:HAVAU

Intrinsic Alpha fair value

Locked

Current Price

$10.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.